News

Latus Bio Announces IND Clearance of LTS-101 for CLN2 Disease and Receipt of Fast Track, Orphan Drug, and Rare Pediatric Disease Designations

December 2, 2025

Trigger warning: Pennsylvania’s politicians will find this article offensive

November 17, 2025

ThirdLaw Molecular Rebrands as Ladder Bio; Announces $5.5M Seed Financing Led by Medical Excellence Capital and Appoints Eric Heil as Chief Executive Officer

November 12, 2025

Vittoria Biotherapeutics Announces Presentation of First-in-Human Interim Phase1 Data for VIPER-101 at ASH2025

November 10, 2025

Latus Bio Launches AI/ML Strategy to Transform AAV Gene Therapy, Adds Two Leading Experts in Peptide and Protein Modeling to Scientific Advisory Board

November 3, 2025

Venture Capital Gap Pushes Philadelphia Down in Biopharma Rankings

August 20, 2025

Penn Nobel Prize winner Dr. Drew Weissman launches startup MasterSwitch Bio

June 19, 2025

MasterSwitch Bio voted winner of 2025 Entrepreneur Spotlight pitch competition, receives $250,000 investment – PA Bio Center

June 6, 2025

Latus Bio Unveils AAV-Ep+ Capsid Variant Capable of Unprecedented Protein Production in the Brain

May 14, 2025

Blue Bell’s ThirdLaw Molecular is Creating Science that Looks Like Magic

February 3, 2025

ThirdLaw Molecular Inc. Launches its Groundbreaking Platform for Targeted Drug Discovery with a 4.5-Billion Molecule DNA-Encoded Library of Spiroligomer™ Macromolecules

January 9, 2025

Vittoria Biotherapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of VIPER-101

December 12, 2024

Vittoria Biotherapeutics Completes $25 Million in Private Financing to Propel Groundbreaking Cell Therapy Candidates

November 12, 2024

Hula Therapeutics lands $250,000 investment for winning Pennsylvania Biotech Center pitch competition

July 19, 2024

Hula Therapeutics voted winner of 2024 Entrepreneur Spotlight pitch competition, receives $250,000 investment – PA Bio Center

July 19, 2024

Taking it to a new level: Pennsylvania Biotechnology Center to hold $250,000 pitch competition – PA Bio Center

June 10, 2024

Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing

May 2, 2024

Hatch BioFund Announces New Partnership with Brandywine Realty Trust

December 20, 2023

Vittoria Biotherapeutics Announces FDA Clearance of IND Application for VIPER-101 to Treat T-Cell Lymphoma

December 7, 2023

The Wistar Institute, Pennsylvania Biotechnology Center and Baruch S. Blumberg Institute Forge Strategic Collaboration to Support Regional Biotech Startups

May 9, 2023

Philly’s Biotech Scene Needs More Local Money — Now

May 8, 2023

B+labs at Cira Centre Fully Occupied and Open

May 9, 2022